A detailed history of Quadrant Capital Group LLC transactions in Amgen Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 8,005 shares of AMGN stock, worth $2.53 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
8,005
Previous 7,459 7.32%
Holding current value
$2.53 Million
Previous $2.12 Million 17.97%
% of portfolio
0.19%
Previous 0.17%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$262.75 - $319.31 $143,461 - $174,343
546 Added 7.32%
8,005 $2.5 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $204,610 - $246,990
-761 Reduced 9.26%
7,459 $2.12 Million
Q4 2023

Feb 08, 2024

BUY
$255.7 - $288.46 $206,861 - $233,364
809 Added 10.92%
8,220 $2.37 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $298,019 - $369,999
1,363 Added 22.54%
7,411 $1.99 Million
Q2 2023

Aug 09, 2023

SELL
$214.27 - $253.37 $271,051 - $320,513
-1,265 Reduced 17.3%
6,048 $1.34 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $171,826 - $209,427
761 Added 11.61%
7,313 $1.77 Million
Q4 2022

Feb 10, 2023

BUY
$229.03 - $291.01 $100,544 - $127,753
439 Added 7.18%
6,552 $1.72 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $44,443 - $50,123
198 Added 3.35%
6,113 $1.38 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $45,219 - $50,321
196 Added 3.43%
5,915 $1.44 Million
Q1 2022

May 06, 2022

BUY
$219.27 - $242.57 $126,957 - $140,448
579 Added 11.26%
5,719 $1.38 Million
Q4 2021

Feb 01, 2022

SELL
$198.88 - $227.6 $284,000 - $325,012
-1,428 Reduced 21.74%
5,140 $1.16 Million
Q3 2021

Nov 12, 2021

BUY
$212.27 - $248.7 $197,623 - $231,539
931 Added 16.52%
6,568 $1.4 Million
Q2 2021

Aug 09, 2021

BUY
$233.58 - $259.14 $42,277 - $46,904
181 Added 3.32%
5,637 $1.37 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $159,331 - $185,674
718 Added 15.15%
5,456 $1.36 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $9,737 - $11,595
-45 Reduced 0.94%
4,738 $1.09 Million
Q3 2020

Nov 13, 2020

SELL
$234.65 - $260.95 $297,301 - $330,623
-1,267 Reduced 20.94%
4,783 $1.22 Million
Q2 2020

Aug 13, 2020

SELL
$197.81 - $242.74 $599,759 - $735,987
-3,032 Reduced 33.38%
6,050 $1.43 Million
Q1 2020

May 15, 2020

BUY
$182.24 - $241.7 $436,647 - $579,113
2,396 Added 35.84%
9,082 $1.84 Million
Q4 2019

Feb 03, 2020

BUY
$189.21 - $243.2 $167,072 - $214,745
883 Added 15.22%
6,686 $1.58 Million
Q3 2019

Oct 24, 2019

BUY
$174.11 - $208.62 $248,629 - $297,909
1,428 Added 32.64%
5,803 $1.1 Million
Q2 2019

Jul 24, 2019

SELL
$166.7 - $195.41 $106,187 - $124,476
-637 Reduced 12.71%
4,375 $784,000
Q1 2019

Apr 29, 2019

BUY
$180.87 - $203.88 $190,636 - $214,889
1,054 Added 26.63%
5,012 $928,000
Q4 2018

Jan 17, 2019

BUY
$178.4 - $208.25 $15,164 - $17,701
85 Added 2.19%
3,958 $749,000
Q2 2018

Aug 09, 2018

BUY
$166.05 - $186.51 $1,660 - $1,865
10 Added 0.26%
3,873 $692,000
Q1 2018

May 10, 2018

BUY
$169.43 - $198.0 $18,467 - $21,582
109 Added 2.9%
3,863 $639,000
Q4 2017

Jan 31, 2018

SELL
$168.79 - $188.59 $4,388 - $4,903
-26 Reduced 0.69%
3,754 $640,000
Q3 2017

Oct 13, 2017

BUY
$167.29 - $191.0 $17,900 - $20,437
107 Added 2.91%
3,780 $691,000
Q2 2017

Aug 15, 2017

BUY
N/A
3,673
3,673 $576,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.